Dominik Dudziński
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dominik Dudziński has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Anna Sobstyl
Medical University of Lublin
3 shared publications - Aleksandra Borkowska
Uniwersytet Medyczny w Lublinie
2 shared publications - Aleksandra Chałupnik
Medical University of Lublin
2 shared publications - Ewelina Grywalska
Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland
2 shared publications - Paulina Mertowska
Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland
2 shared publications - Sebastian Mertowski
Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland
2 shared publications
Latest Publications
- Open Access
Expression of Toll-like Receptors on Lymphocyte Subpopulations and Their Soluble Forms in Serum and Urine of Women with Endometriosis
Introduction: Endometriosis is a chronic inflammatory disease affecting women of reproductive age, often accompanied by chronic pelvic pain and infertility. Despite numerous studies, its pathogenesis remains incompletely understood. Increasing evidence indicates the important role of immunological disorders, especially in the mechanisms of innate immunity and Toll-like receptors (TLRs). Study objective: This study aimed to assess the expression of selected TLRs (TLR2, TLR3, TLR4, TLR7, TLR8, and TLR9) on peripheral blood lymphocyte subpopulations (CD4+, CD8+, and CD19+ cells) in patients diagnosed with endometriosis and to quantify the levels of their soluble forms in serum and urine. This study was conducted on patients who were not undergoing hormonal bridging therapy and were not using any form of hormonal contraception to eliminate potential confounding effects on immune parameters. Methods: Flow cytometric analysis of TLR expression on peripheral blood lymphocytes was performed, and the levels of their soluble forms in serum and urine samples were determined. Additionally, ROC curve analysis was used to evaluate the diagnostic potential of the studied parameters. Results: We found increased expression of TLRs in lymphocyte populations in patients with endometriosis compared to the control group, suggesting their involvement in both local and systemic immune responses. In addition, ROC analysis showed the diagnostic potential of TLR expression in differentiating patients with endometriosis from healthy women, and it may also identify disease subtypes. Conclusions: The findings support the role of TLRs in the immunopathogenesis of endometriosis and highlight their promise as diagnostic biomarkers and therapeutic targets. Further studies on larger patient cohorts and functional signaling analyses are warranted.
Open AccessExpression of Toll-like Receptors on Lymphocyte Subpopulations and Their Soluble Forms in Serum and Urine of Women with Endometriosis
Introduction: Endometriosis is a chronic inflammatory disease affecting women of reproductive age, often accompanied by chronic pelvic pain and infertility. Despite numerous studies, its pathogenesis remains incompletely understood. Increasing evidence indicates the important role of immunological disorders, especially in the mechanisms of innate immunity and Toll-like receptors (TLRs). Study objective: This study aimed to assess the expression of selected TLRs (TLR2, TLR3, TLR4, TLR7, TLR8, and TLR9) on peripheral blood lymphocyte subpopulations (CD4+, CD8+, and CD19+ cells) in patients diagnosed with endometriosis and to quantify the levels of their soluble forms in serum and urine. This study was conducted on patients who were not undergoing hormonal bridging therapy and were not using any form of hormonal contraception to eliminate potential confounding effects on immune parameters. Methods: Flow cytometric analysis of TLR expression on peripheral blood lymphocytes was performed, and the levels of their soluble forms in serum and urine samples were determined. Additionally, ROC curve analysis was used to evaluate the diagnostic potential of the studied parameters. Results: We found increased expression of TLRs in lymphocyte populations in patients with endometriosis compared to the control group, suggesting their involvement in both local and systemic immune responses. In addition, ROC analysis showed the diagnostic potential of TLR expression in differentiating patients with endometriosis from healthy women, and it may also identify disease subtypes. Conclusions: The findings support the role of TLRs in the immunopathogenesis of endometriosis and highlight their promise as diagnostic biomarkers and therapeutic targets. Further studies on larger patient cohorts and functional signaling analyses are warranted.
- Open Access
- 18 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 22, 54326
Correlation between gut microbiota dysbiosis and colorectal cancer: review
Introduction and Purpose: The human gut microbiota, comprising a diverse consortium of approximately 100 trillion microorganisms, is integral to maintaining health and modulating disease processes. Its development begins at birth, influenced by maternal microbiota and environmental factors. Dysbiosis, defined as an imbalance in the gut microbial composition, has been implicated in a range of gastrointestinal pathologies, including colorectal cancer (CRC). This review endeavors to elucidate the relationship between gut microbiota and CRC, examining the impact of specific bacterial taxa on the pathogenesis CRC. Description of the State of Knowledge: Gut microbiota encompasses a multitude of microbial species, with their composition differing along the gastrointestinal tract. Healthy gut microbiota perform essential functions such as pathogen protection, metabolic processes, and immune system modulation. Factors like diet and genetics significantly influence microbial composition. Dysbiosis contributes to CRC through inflammation, genotoxin production, and immune modulation. Specific bacteria, such as Fusobacterium nucleatum and Bacteroides fragilis, are associated with CRC. Mechanisms of carcinogenesis include bacterial adherence, invasion of epithelial cells, and activation of pro-inflammatory pathways. Summary:Understanding the gut microbiota's role in CRC highlights the importance of maintaining a balanced microbiome for cancer prevention. Dietary interventions promoting beneficial bacteria and reducing harmful species could mitigate CRC risk. Further research should prioritize the identification of microbial biomarkers for early CRC detection and the development of therapeutic strategies aimed at modulating the gut microbiota. These efforts will enhance CRC prevention and treatment modalities.
- 18 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 22, 54326
Open AccessCorrelation between gut microbiota dysbiosis and colorectal cancer: review
Introduction and Purpose: The human gut microbiota, comprising a diverse consortium of approximately 100 trillion microorganisms, is integral to maintaining health and modulating disease processes. Its development begins at birth, influenced by maternal microbiota and environmental factors. Dysbiosis, defined as an imbalance in the gut microbial composition, has been implicated in a range of gastrointestinal pathologies, including colorectal cancer (CRC). This review endeavors to elucidate the relationship between gut microbiota and CRC, examining the impact of specific bacterial taxa on the pathogenesis CRC. Description of the State of Knowledge: Gut microbiota encompasses a multitude of microbial species, with their composition differing along the gastrointestinal tract. Healthy gut microbiota perform essential functions such as pathogen protection, metabolic processes, and immune system modulation. Factors like diet and genetics significantly influence microbial composition. Dysbiosis contributes to CRC through inflammation, genotoxin production, and immune modulation. Specific bacteria, such as Fusobacterium nucleatum and Bacteroides fragilis, are associated with CRC. Mechanisms of carcinogenesis include bacterial adherence, invasion of epithelial cells, and activation of pro-inflammatory pathways. Summary:Understanding the gut microbiota's role in CRC highlights the importance of maintaining a balanced microbiome for cancer prevention. Dietary interventions promoting beneficial bacteria and reducing harmful species could mitigate CRC risk. Further research should prioritize the identification of microbial biomarkers for early CRC detection and the development of therapeutic strategies aimed at modulating the gut microbiota. These efforts will enhance CRC prevention and treatment modalities.
- Open Access
- 20 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (12) , 6775
The PD-1/PD-L1 Gateway: Peripheral Immune Regulation in the Pathogenesis of Endometriosis
Endometriosis is a chronic inflammatory disease characterized by the presence of endometrial-like tissue outside the uterine cavity, causing pain and infertility. Despite the rather unclear etiopathogenesis, recent studies suggest the involvement of the immune system in the development and progression of endometriosis. The role of the PD-1/PD-L1 axis in the modulation of the immune response in this disease seems to be particularly interesting. This preliminary study aimed to investigate the expression of PD-1 and PD-L1 on T and B lymphocytes in peripheral blood in patients with endometriosis to assess their potential impact on disease progression. Our study involved peripheral blood samples from 80 patients diagnosed with endometriosis and 20 healthy women as a control group were analyzed. Flow cytometry was used to assess the expression of PD-1 and PD-L1 on T and B lymphocytes, and enzyme-linked immunosorbent assays were used to assess their soluble forms in serum and peritoneal fluid.in our research we observe significantly higher expression of PD-1 and PD-L1 on T and B lymphocytes was found in patients with endometriosis compared to the control group. Higher expression of both tested molecules correlated with the stage of endometriosis. The results of our preliminary studies indicate a potential role of the PD-1/PD-L1 axis in the modulation of the immune response in endometriosis. Modified expression of these proteins may contribute to immune evasion by ectopic tissues, supporting their survival and proliferation. These findings suggest that targeting PD-1/PD-L1 could be explored as a therapeutic option for the treatment of endometriosis, though further research with larger sample sizes is necessary to confirm these results and clarify the role of PD-1/PD-L1 in the pathogenesis of the disease.
- 20 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (12) , 6775
Open AccessThe PD-1/PD-L1 Gateway: Peripheral Immune Regulation in the Pathogenesis of Endometriosis
Endometriosis is a chronic inflammatory disease characterized by the presence of endometrial-like tissue outside the uterine cavity, causing pain and infertility. Despite the rather unclear etiopathogenesis, recent studies suggest the involvement of the immune system in the development and progression of endometriosis. The role of the PD-1/PD-L1 axis in the modulation of the immune response in this disease seems to be particularly interesting. This preliminary study aimed to investigate the expression of PD-1 and PD-L1 on T and B lymphocytes in peripheral blood in patients with endometriosis to assess their potential impact on disease progression. Our study involved peripheral blood samples from 80 patients diagnosed with endometriosis and 20 healthy women as a control group were analyzed. Flow cytometry was used to assess the expression of PD-1 and PD-L1 on T and B lymphocytes, and enzyme-linked immunosorbent assays were used to assess their soluble forms in serum and peritoneal fluid.in our research we observe significantly higher expression of PD-1 and PD-L1 on T and B lymphocytes was found in patients with endometriosis compared to the control group. Higher expression of both tested molecules correlated with the stage of endometriosis. The results of our preliminary studies indicate a potential role of the PD-1/PD-L1 axis in the modulation of the immune response in endometriosis. Modified expression of these proteins may contribute to immune evasion by ectopic tissues, supporting their survival and proliferation. These findings suggest that targeting PD-1/PD-L1 could be explored as a therapeutic option for the treatment of endometriosis, though further research with larger sample sizes is necessary to confirm these results and clarify the role of PD-1/PD-L1 in the pathogenesis of the disease.
- Open Access
- 11 April 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 20 (1) , 204-217
Systemic sclerosis – review of current data and latest reports
Introduction: Systemic scleroderma (SSc) is an autoimmune disease characterized by fibrosis of the skin and internal organs, vasculopathy and dysregulation of the immune system. It has the highest mortality rate among rheumatologic diseases. SSc causes high economic and social costs. Aim of the study: The purpose of this review is to present the current state of knowledge and recent reports on the pathophysiology, clinical manifestation and treatment of SSc. Materials and methods: A search was conducted using PubMed and GoogleScholar databases. Articles were searched in English using the following keywords: "systemic sclerosis", "scleroderma", "treatment", "symptoms", "pathophysiology". Conclusions: Although the prognosis of SSc remains poor, optimized patient diagnosis along with ongoing advances in therapy could significantly impact the effectiveness of disease management in the near future. It is anticipated that there will be a growing need for further development of combination therapies to better treat this complex disease.
- 11 April 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 20 (1) , 204-217
Open AccessSystemic sclerosis – review of current data and latest reports
Introduction: Systemic scleroderma (SSc) is an autoimmune disease characterized by fibrosis of the skin and internal organs, vasculopathy and dysregulation of the immune system. It has the highest mortality rate among rheumatologic diseases. SSc causes high economic and social costs. Aim of the study: The purpose of this review is to present the current state of knowledge and recent reports on the pathophysiology, clinical manifestation and treatment of SSc. Materials and methods: A search was conducted using PubMed and GoogleScholar databases. Articles were searched in English using the following keywords: "systemic sclerosis", "scleroderma", "treatment", "symptoms", "pathophysiology". Conclusions: Although the prognosis of SSc remains poor, optimized patient diagnosis along with ongoing advances in therapy could significantly impact the effectiveness of disease management in the near future. It is anticipated that there will be a growing need for further development of combination therapies to better treat this complex disease.
- Open Access
- 4 April 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 19 (1) , 119-128
Raising awareness about the importance of chickenpox vaccination in children
Introduction: Varicella is an acute infectious disease caused by the Varicella zoster virus. It is among one of the most contagious infectious diseases. The main symptoms of the disease are an itchy, papular and vesicular rash on the trunk, face, scalp, extremities, mucous membranes. In addition, there is fever, malaise, headache and muscle aches, enlargement of lymph nodes. In most cases, varicella is mild, but 2-6% of patients may develop dangerous complications. The most common complications include bacterial skin infections, neurological symptoms and acute thrombocytopenia. Aim: The purpose of this study is to present the severe and complicated course of varicella in a 12-month-old patient. Results: On the day of admission, the patient presented symptoms of an exacerbation of the course of varicella. The main symptoms were smallpox eruptions, increasing fever track, and enlarged and painful lymph nodes. During his stay, the patient's condition indicated a severe course of varicella. It was complicated by infection of the skin, subcutaneous tissue and lymph nodes. In addition, tests showed Epstein-Barr virus (EBV) infection and positivity for cat scratch disease. He also developed zoster during his hospitalization. Throughout his stay in the hospital, many tests and consultations were carried out to clarify his symptoms. With appropriate treatment, the patient's condition improved and he was able to be discharged home after a 3-week hospitalization. Conclusions: The presented case shows the severe course of varicella. Due to recommendations and the patient's too young age, he could not be vaccinated against VZV. In each patient, the course of the disease is unpredictable. Vaccination protects against severe symptoms, and also reduces the risk of developing zoster in the future. In addition, long-term immunity can be acquired through vaccination.
- 4 April 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 19 (1) , 119-128
Open AccessRaising awareness about the importance of chickenpox vaccination in children
Introduction: Varicella is an acute infectious disease caused by the Varicella zoster virus. It is among one of the most contagious infectious diseases. The main symptoms of the disease are an itchy, papular and vesicular rash on the trunk, face, scalp, extremities, mucous membranes. In addition, there is fever, malaise, headache and muscle aches, enlargement of lymph nodes. In most cases, varicella is mild, but 2-6% of patients may develop dangerous complications. The most common complications include bacterial skin infections, neurological symptoms and acute thrombocytopenia. Aim: The purpose of this study is to present the severe and complicated course of varicella in a 12-month-old patient. Results: On the day of admission, the patient presented symptoms of an exacerbation of the course of varicella. The main symptoms were smallpox eruptions, increasing fever track, and enlarged and painful lymph nodes. During his stay, the patient's condition indicated a severe course of varicella. It was complicated by infection of the skin, subcutaneous tissue and lymph nodes. In addition, tests showed Epstein-Barr virus (EBV) infection and positivity for cat scratch disease. He also developed zoster during his hospitalization. Throughout his stay in the hospital, many tests and consultations were carried out to clarify his symptoms. With appropriate treatment, the patient's condition improved and he was able to be discharged home after a 3-week hospitalization. Conclusions: The presented case shows the severe course of varicella. Due to recommendations and the patient's too young age, he could not be vaccinated against VZV. In each patient, the course of the disease is unpredictable. Vaccination protects against severe symptoms, and also reduces the risk of developing zoster in the future. In addition, long-term immunity can be acquired through vaccination.